Last reviewed · How we verify
NCT05922462
Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes
NA trial testing Greek yogurt in Bone Growth Abnormal in 40 participants. Currently enrolling.
30 August 2025
Quick facts
| Lead sponsor | Brock University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 1 September 2023 |
| Primary completion | 30 August 2025 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Greek yogurt
- Whey protein
Conditions studied
- Bone Growth Abnormal — all drugs for Bone Growth Abnormal →
- Inflammation — all drugs for Inflammation →
Sponsor
Brock University
Who can join
Adults 15 to 22, any sex, with Bone Growth Abnormal or Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical activity and dairy consumption during growth and development are each known to improve peak bone mass in young adults. Peak bone mass, the maximum amount of bone a person will have in their lifetime, is typically reached in the early 20's in females and late 20's in males. However, evidence suggests that young people do not consume enough dairy to maximize their bone mass. The resulting effect in peak bone mass can be troublesome, particularly for athletes, such as volleyball players. This study aims to determine whether increased dairy consumption combined with training can have an additive effect on the physiology of young competitive athletes. Specifically, we will examine whether Greek yogurt consumption will lead to beneficial changes in bone metabolism and inflammation, in adolescent and young adult, male and female athletes, similar to those observed with whey protein supplementation. Many athletes choose exclusively protein supplementation and miss out on other nutrients vital for healthy growth and development. By examining the benefits of Greek yogurt across different athlete age groups and sexes, this work will help reshape the attitudes, beliefs, and behaviours surrounding diet of young athletes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Greek Yogurt Compared with Whey Protein Supplementation in Adolescent Athletes Throughout a Competitive Season.
Bell M, Narciso PH, Miskolczi E, Retsidou MI, et al · · 2026 · PMID 41941960 · DOI 10.1016/j.tjnut.2026.101524
Verify or expand the search:
- PubMed search for NCT05922462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Greek yogurt
Trials testing the same drug.
- NCT06530394 — Effects of Increased Greek Yogurt Consumption in Senior Adults · NA · completed
- NCT06041087 — Bone and Inflammatory Outcomes - Nutrition and Exercise Trials · NA · completed
- NCT05876260 — Effect of Post-exercise Nutrition on Glycemia in Women · NA · completed
Other Brock University trials
Trials by the same sponsor.
- NCT04345250 — Bone Response to Exercise and Energy Restriction in Young Adults · NA · suspended
- NCT06530394 — Effects of Increased Greek Yogurt Consumption in Senior Adults · NA · completed
- NCT04670133 — Inulin Supplementation During Sanative Therapy to Further Improve Periodontal Healing · NA · withdrawn
- NCT04380155 — Cycling Duration and Bone Markers in in Active Young Adults · NA · withdrawn
- NCT03977922 — A Pilot Nutrition Program for Spinal Cord Injury and MS · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05922462 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brock University
- Last refreshed: 31 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05922462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing